Abstract: Modern biobanks are rapidly evolving from static storage facilities into dynamic, AI-driven digital ecosystems. By pairing deep longitudinal electronic health records with multiomic data, large-scale repositories like the UK Biobank and Singapore’s PRECISE-SG100K are shifting research away from isolated snapshots of health. This scale enables scientists to track complex disease progression across vast populations, turning raw biological data into reproducible, real-world clinical impact.
While genomics reveals our static baseline risk, proteomics captures real-time physiological shifts, making it a critical tool for early disease detection. Recent studies demonstrate that analyzing thousands of circulating proteins can identify early biological markers of cancer up to 7 years before clinical symptoms appear. Coupled with AI-driven analytics, standardized collection protocols, and diverse population cohorts, next-generation biobanks are laying the groundwork for earlier diagnostics, precise patient stratification, and accelerated drug discovery.
Get the full article here: https://www.technologynetworks.com/proteomics/articles/biobanks-proteomics-and-ai-converge-to-advance-precision-medicine-414413
